Systemic lupus erythematosus Trials in Chengdu, China
Conditions / Systemic lupus erythematosus / Chengdu, China
Clinical trials for Systemic lupus erythematosus investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05639114 | Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01345253 | GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia | COMPLETED | PHASE3 |
| NCT05617677 | A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06161116 | Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006) | TERMINATED | PHASE2 |
| NCT05843643 | Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus | RECRUITING | PHASE3 |
| NCT06617325 | A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus | RECRUITING | PHASE3 |
| NCT06859931 | Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE) | NOT_YET_RECRUITING | PHASE2 |
| NCT05162586 | The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) | COMPLETED | PHASE2 |
| NCT05687526 | A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus | COMPLETED | PHASE1 |
| NCT06133972 | Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). | RECRUITING | PHASE3 |